Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMPOWUR Extension
NCT03583372Phase 3Completed
- Sponsor
- Urovant Sciences
- Start
- Jun 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vibegron in overactive bladder (OAB), sponsored by Urovant Sciences. Started Jun 2018; status: completed.
02
Drugs
vibegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT03583372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03583372.